Armistice Capital, LLC Bicycle Therapeutics PLC Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Armistice Capital, LLC holds 2,672,000 shares of BCYC stock, worth $21.5 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
2,672,000
Previous 2,196,000
21.68%
Holding current value
$21.5 Million
Previous $30.7 Million
26.21%
% of portfolio
0.35%
Previous 0.43%
Shares
9 transactions
Others Institutions Holding BCYC
# of Institutions
102Shares Held
42.9MCall Options Held
15.6KPut Options Held
27.7K-
Baker Bros. Advisors LP New York, NY10.9MShares$87.5 Million1.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$29.7 Million0.08% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$27.8 Million7.08% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$21.4 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY1.81MShares$14.6 Million0.88% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $239M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...